Products Categories
| CAS No.: | 157115-85-0 |
|---|---|
| Name: | Noopept |
| Molecular Structure: | |
 |
|
| Formula: | C17H22N2O4 |
| Molecular Weight: | 318.3676 |
| Synonyms: | Glycine,1-(phenylacetyl)-L-prolyl-, ethyl ester (9CI);Glycine,N-[1-(phenylacetyl)-L-prolyl]-, ethyl ester;GVS 111;Glycine,1-(2-phenylacetyl)-L-prolyl-, ethyl ester;SGS 111;Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester; |
| EINECS: | 1592732-453-0 |
| Density: | 1.202g/cm3 |
| Melting Point: | 94.0 to 98.0 °C |
| Boiling Point: | 547.3°Cat760mmHg |
| Flash Point: | 284.8°C |
| Solubility: | |
| Appearance: | white powder |
| Hazard Symbols: | |
| Risk Codes: | |
| Safety: | |
| Transport Information: | |
| PSA: | 75.71000 |
| LogP: | 1.22820 |
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
IUPAC Name: Ethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
Synonyms of Noopept (CAS NO.157115-85-0): ethyl phenylacetyl-Pro-Gly ; GVS 111 ; GVS-111 ; Glycine, N-(1-(phenylacetyl)-L-prolyl)-, ethyl ester ; Glycine, 1-(phenylacetyl)-L-prolyl-, ethyl ester
CAS NO: 157115-85-0
Classification Code: Nootropic
Molecular Formula of Noopept (CAS NO.157115-85-0): C17H22N2O4
Molecular Weight: 318.3676
Molecular Structure:
.png)
Polar Surface Area: 66.92 Å2
Index of Refraction: 1.548
Molar Refractivity: 84.17 cm3
Molar Volume: 264.7 cm3
Surface Tension: 49.7 dyne/cm
Density: 1.202 g/cm3
Flash Point: 284.8 °C
Enthalpy of Vaporization: 82.67 kJ/mol
Boiling Point: 547.3 °C at 760 mmHg
Vapour Pressure: 4.93E-12 mmHg at 25°C
Noopept (CAS NO.157115-85-0) is a drug promotion. It is from the drugs and share similar mechanisms of action, racetam family income, but up to 1,000 times higher than the prototype racetam potent drug, piracetam. Animal studies have shown noopept is to protect and enhance neurological test different memory. Unusual is that peptides derived compounds, noopept also showed oral bioavailability and good blood-brain barrier permeability, and human studies have shown promising and the treatment of Alzheimer's disease has a potential application of the results.
